Astrana Health, Inc.
ASTH
$23.18
$0.140.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 73.12% | -39.99% | -62.84% | -63.86% | -65.45% |
| Total Other Revenue | 68.12% | 53.26% | 57.53% | 49.89% | 32.89% |
| Total Revenue | 68.17% | 51.97% | 54.81% | 46.72% | 29.71% |
| Cost of Revenue | 77.75% | 61.02% | 63.42% | 50.48% | 31.66% |
| Gross Profit | 14.27% | 5.43% | 11.49% | 26.25% | 19.73% |
| SG&A Expenses | 24.27% | 21.56% | 21.32% | 36.87% | 51.80% |
| Depreciation & Amortization | 51.70% | 34.03% | 59.99% | 57.36% | 46.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.44% | 56.88% | 59.35% | 49.39% | 33.49% |
| Operating Income | -14.39% | -25.09% | -12.10% | 5.60% | -16.13% |
| Income Before Tax | -63.89% | -45.86% | -29.67% | -10.04% | -15.83% |
| Income Tax Expenses | -21.34% | -16.04% | -15.78% | -3.45% | -38.50% |
| Earnings from Continuing Operations | -83.10% | -58.50% | -36.85% | -13.69% | 0.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -104.13% | -231.37% | -2,275.13% | -336.51% | 138.96% |
| Net Income | -84.73% | -63.08% | -43.92% | -28.93% | 39.93% |
| EBIT | -14.39% | -25.09% | -12.10% | 5.60% | -16.13% |
| EBITDA | 0.52% | -14.12% | -0.05% | 14.57% | -7.21% |
| EPS Basic | -85.75% | -64.34% | -45.29% | -30.42% | 37.84% |
| Normalized Basic EPS | -51.69% | -47.22% | -31.51% | -28.52% | -4.59% |
| EPS Diluted | -85.70% | -64.67% | -45.52% | -30.91% | 37.52% |
| Normalized Diluted EPS | -51.63% | -47.32% | -31.69% | -28.73% | -4.64% |
| Average Basic Shares Outstanding | 1.65% | 1.45% | 1.22% | 0.96% | 3.92% |
| Average Diluted Shares Outstanding | 1.42% | 1.45% | 1.31% | 1.10% | 4.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.32% | -0.73% | -0.84% | -1.00% | 10.83% |